{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:20:58Z","timestamp":1779139258706,"version":"3.51.4"},"reference-count":2,"publisher":"American College of Physicians","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.acpjournals.org\/journal\/aim\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Intern Med"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.7326\/annals-26-01143-jc","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:00:35Z","timestamp":1777928435000},"page":"JC52","source":"Crossref","is-referenced-by-count":0,"title":["In postmenopausal women at high risk for fracture, romosozumab for 3 mo was noninferior to 12 mo for increasing total hip BMD at 1 y"],"prefix":"10.7326","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1006-5118","authenticated-orcid":false,"given":"Yu Qing","family":"Huang","sequence":"first","affiliation":[{"name":"University of Toronto, Toronto, Ontario, Canada (Y.Q.H., J.W.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5296-6013","authenticated-orcid":false,"given":"Jennifer","family":"Watt","sequence":"additional","affiliation":[{"name":"University of Toronto, Toronto, Ontario, Canada (Y.Q.H., J.W.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"ACP Journal Club Editorial Team at McMaster University","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4285","reference":[{"key":"ANNALS-26-01143-R1","doi-asserted-by":"crossref","unstructured":"Qaseem A, Hicks LA, Etxeandia-Ikobaltzeta I, et al.\n                      Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians. Ann Intern Med. 2023;176:224-238. [PMID:36592456]","DOI":"10.7326\/M22-1034"},{"key":"ANNALS-26-01143-R2","doi-asserted-by":"crossref","unstructured":"Saag KG, Petersen J, Brandi ML, et al.\n                      Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med. 2017;377:1417-1427. [PMID:28892457]","DOI":"10.1056\/NEJMoa1708322"}],"container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.acpjournals.org\/doi\/pdf\/10.7326\/ANNALS-26-01143-JC","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.acpjournals.org\/doi\/full-xml\/10.7326\/ANNALS-26-01143-JC","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:03:25Z","timestamp":1779138205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/ANNALS-26-01143-JC"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":2,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.7326\/ANNALS-26-01143-JC"],"URL":"https:\/\/doi.org\/10.7326\/annals-26-01143-jc","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"value":"0003-4819","type":"print"},{"value":"1539-3704","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}